Malika Goughoulte-Ait
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Enhanced hepatitis B virus-specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection.
Journal: Hepatology (Baltimore, Md.)
Published: January 31, 2024
TRIM16 Overexpression in HEK293T Cells Results in Cell Line-Specific Antiviral Activity.
Journal: Pathogens (Basel, Switzerland)
Published: January 31, 2023
A translational strategy employing physiologically based modelling to predict the pharmacological active dose of RO7119929, an oral prodrug of a targeted cancer immunotherapy TLR7 agonist.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: August 25, 2022
Host Cell Restriction Factors of Paramyxoviruses and Pneumoviruses.
Journal: Viruses
Published: November 13, 2020
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.
Journal: The Journal of experimental medicine
Published: April 29, 2020
TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands.
Journal: Antiviral research
Published: January 15, 2018
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.
Journal: Scientific reports
Published: October 25, 2017
Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.
Journal: Antimicrobial agents and chemotherapy
Published: August 23, 2017
Early inhibition of hepatocyte innate responses by hepatitis B virus.
Journal: Journal of hepatology
Published: November 24, 2014
Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.
Journal: Journal of hepatology
Published: June 05, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026